IBS market to reach $1.5 billion by 2023 Rx trends 2015: Specialty drug costs Eisai introduces savings card for weight-loss drug Belviq FDA approves Consentyx from Novartis Boehringer Ingelheim's Spiriva Respimat now available at pharmacies Age indication of Pediculicide Natroba (spinosad) to include children 6 months and older Supreme Court ruling protects Teva's Copaxone patent Flu incidence on the rise along the coasts CDC: Flu shots this year reduce risk of seeing a doctor by 23% FDA approves AbbVie's Duopa First Previous 144 145 146 147 148 Next Last